Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease

被引:28
作者
Matsumoto, T
Shima, M
Fukuda, K
Nogami, K
Giddings, JC
Murakami, T
Tanaka, I
Yoshioka, A
机构
[1] Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan
[2] Cardiff Univ, Coll Med, Dept Haematol, Cardiff CF1 3NS, S Glam, Wales
关键词
acquired hemophilia; autoantibody; factor VIII activity; factor VIII antigen;
D O I
10.1016/S0049-3848(01)00385-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of a factor VIII autoantibody results in a severe hemorrhagic diathesis known as acquired hemophilia A. Underlying pathologies, such as autoimmune disease or chronic inflammatory disease, are observed in about half of the patients. We have investigated a total of 16 cases with acquired hemophilia A and divided the patients into two groups according to the presence or absence of other clinical conditions. Group A comprised nine cases with no detectable associated pathology. Group B consisted of seven cases with other clinical diagnoses. Significant levels of factor VIII activity (FVIII:C) and factor VIII antigen (FVIII:Ag) were detected in Group A and the pattern of FVIII:C inactivation was characteristic of Type 2 inhibitors. In contrast, no FVIII:C was detected in Group B and, in five of seven cases, the inhibitory pattern was Type 1. IgG(4) antibody subclass specificity was dominant in both groups. IgG1 antibody reactivity was higher in Group B than in Group A. Our results suggested a close relationship between the presence of underlying disease and immuno-logical and coagulation characteristics in acquired hemophilia A. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 14 条
[1]   MODE OF ACTION OF ANTIBODIES WHICH DESTROY FACTOR-VIII .1. ANTIBODIES WHICH HAVE SECOND-ORDER CONCENTRATION GRAPHS [J].
BIGGS, R ;
BORRETT, R ;
AUSTEN, DEG ;
DENSON, KWE ;
RIZZA, CR .
BRITISH JOURNAL OF HAEMATOLOGY, 1972, 23 (02) :125-&
[2]  
GREEN D, 1981, THROMB HAEMOSTASIS, V45, P200
[3]  
HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215
[4]  
Hoyer L W, 1984, Prog Clin Biol Res, V150, P73
[5]   ABNORMAL FACTOR-VIII HIROSHIMA - DEFECT IN CRUCIAL PROTEOLYTIC CLEAVAGE BY THROMBIN AT ARG(1689) DETECTED BY A NOVEL ELISA [J].
KAMISUE, S ;
SHIMA, M ;
NISHIMURA, T ;
TANAKA, I ;
NAKAI, H ;
MORICHIKA, S ;
TAKATA, N ;
KURAMOTO, A ;
YOSHIOKA, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (01) :106-111
[6]  
KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869
[7]   Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis [J].
Nogami, K ;
Shima, M ;
Giddings, JC ;
Hosokawa, K ;
Nagata, M ;
Kamisue, S ;
Suzuki, H ;
Shibata, M ;
Saenko, EL ;
Tanaka, I ;
Yoshioka, A .
BLOOD, 2001, 97 (03) :669-677
[8]   The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies [J].
Prescott, R ;
Nakai, H ;
Saenko, EL ;
Scharrer, I ;
Nilsson, IM ;
Humphries, JE ;
Hurst, D ;
Bray, G ;
Scandella, D .
BLOOD, 1997, 89 (10) :3663-3671
[9]   A MECHANISM FOR INHIBITION OF FACTOR-VIII BINDING TO PHOSPHOLIPID BY VON-WILLEBRAND-FACTOR [J].
SAENKO, EL ;
SCANDELLA, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :13826-13833
[10]  
SAWAMOTO Y, 1992, J NARA MED ASS, V43, P511